Human Focal Segmental Glomerulosclerosis Serum for Research

Our Focal Segmental Glomerulosclerosis Serum is sourced from IRB-consented donors clinically diagnosed with Focal Segmental Glomerulosclerosis. Each sample is processed and frozen within 24 hours of collection to ensure consistency and high quality for disease-specific and immunological studies focused on fsgs.

Product Features

• Collected from clinically confirmed Focal Segmental Glomerulosclerosis donors
• Research Use Only (RUO)
• IRB-approved protocols with documented consent

Donor Metadata

• Diagnosis confirmation
• Age, sex assigned at birth, and ethnicity
• Donor-reported medical history and comorbidities

Applications

• Biomarker discovery for fsgs
• Serum cytokine and protein profiling
• Therapeutic candidate screening and validation

Compliance and Quality Assurance

• IRB-approved and HIPAA-compliant protocols
• Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
• Documentation support available for regulatory review

Ordering and Customization

Focal Segmental Glomerulosclerosis serum is available in standard and custom volumes. For international orders or documentation requirements, please email to ensure compatibility with your country’s regulations.